Lombard Medical, Inc. (EVARF) Investment Research Dashboard
About Lombard Medical, Inc. (EVARF) stock analysis
Get live EVARF stock price $0.00, comprehensive Lombard Medical, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time EVARF stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Lombard Medical, Inc. is a medical technology firm specializing in the creation, production, and distribution of endovascular stent-grafts designed for the repair of aortic aneurysms. The company serves a global market, with operations in the United ...
Company Information
- CEO
- Kurt Lemvigh
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 113
Contact Information
- Address
- 4 Trident Park
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Lombard Medical, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Lombard Medical, Inc.
- ⚠Investors should consider how Lombard Medical, Inc. fits within their overall portfolio allocation
Market Cap
2.79K
Beta
0.81
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare EVARF with peer companies:
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.41K
- Price
- $0.02+0.00% (1D)
- Market cap
- 142.22K
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.08K
- Price
- $0.00+0.00% (1D)
- Market cap
- 453
- Price
- $10.31-3.42% (1D)
- Market cap
- 170.06K
- Price
- $0.00+0.00% (1D)
- Market cap
- 2.29K
- Price
- $0.00+0.00% (1D)
- Market cap
- 14.11K
- Price
- $0.00+0.00% (1D)
- Market cap
- 1.41K
- Price
- $0.00+0.00% (1D)
- Market cap
- 12.75K
- Price
- $0.00+0.00% (1D)
- Market cap
- 156.17K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
73/100 ⭐⭐⭐⭐⭐
- Overall
- +0.6%
- NYSE
- +0.7%
- NASDAQ
- +0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +1.9% | +2.8% | +4.0% | 19.2 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.5% | -0.5% | +3.1% | 22.3 | 74/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.6% | +1.2% | +1.5% | 24.0 | 73/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +1.7% | +0.2% | 25.3 | 66/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.0% | +2.0% | +0.9% | 29.8 | 63/100⭐⭐⭐⭐ |
| Real Estate | +0.4% | +0.9% | -1.6% | 29.5 | 50/100⭐⭐⭐ |
| Energy | -1.7% | -3.3% | -3.7% | 19.2 | 39/100⭐⭐ |
| Utilities | -1.1% | -0.0% | -4.5% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.7% | +0.5% | -9.8% | 30.0 | 21/100⭐ |
| Technology | +0.9% | -1.3% | -6.9% | 40.9 | 18/100⭐ |
| Consumer Cyclical | +0.3% | -1.7% | -6.0% | 42.8 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.